Literature DB >> 15320867

Efficient co-expression of a recombinant staphopain A and its inhibitor staphostatin A in Escherichia coli.

Benedykt Wladyka1, Katarzyna Puzia, Adam Dubin.   

Abstract

Staphopain A is a staphylococcal cysteine protease. Genes encoding staphopain A and its specific inhibitor, staphostatin A, are localized in an operon. Staphopain A is an important staphylococcal virulence factor. It is difficult to perform studies on its interaction with other proteins due to problems in obtaining a sufficient amount of the enzyme from natural sources. Therefore efforts were made to produce a recombinant staphopain A. Sequences encoding the mature form of staphopain A and staphostatin A were PCR-amplified from Staphylococcus aureus genomic DNA and cloned into different compatible expression vectors. Production of staphopain A was observed only when the enzyme was co-expressed together with its specific inhibitor, staphostatin A. Loss of the function mutations introduced within the active site of staphopain A causes the expression of the inactive enzyme. Mutations within the reactive centre of staphostatin A result in abrogation of production of both the co-expressed proteins. These results support the thesis that the toxicity of recombinant staphopain A to the host is due to its proteolytic activity. The coexpressed proteins are located in the insoluble fraction. Ni2+-nitrilotriacetate immobilized metal-affinity chromatography allows for an efficient and easy purification of staphopain A. Our optimized refolding parameters allow restoration of the native conformation of the enzyme, with yields over 10-fold higher when compared with isolation from natural sources.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15320867      PMCID: PMC1134686          DOI: 10.1042/BJ20040958

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  The role and regulation of the extracellular proteases of Staphylococcus aureus.

Authors:  Lindsey Shaw; Ewa Golonka; Jan Potempa; Simon J Foster
Journal:  Microbiology       Date:  2004-01       Impact factor: 2.777

2.  Refolding of Escherichia coli produced membrane protein inclusion bodies immobilised by nickel chelating chromatography.

Authors:  H Rogl; K Kosemund; W Kühlbrandt; I Collinson
Journal:  FEBS Lett       Date:  1998-07-31       Impact factor: 4.124

Review 3.  Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes.

Authors:  A R Khan; M N James
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

4.  Molecular phylogenetic characterization of Streptomyces protease inhibitor family.

Authors:  S Taguchi; S Kojima; M Terabe; Y Kumazawa; H Kohriyama; M Suzuki; K Miura; H Momose
Journal:  J Mol Evol       Date:  1997-05       Impact factor: 2.395

5.  Overexpression, purification, and refolding of a Porphyromonas gingivalis cysteine protease from Escherichia coli.

Authors:  M B Margetts; I G Barr; E A Webb
Journal:  Protein Expr Purif       Date:  2000-04       Impact factor: 1.650

6.  Studies on extracellular proteolytic enzymes from Staphylococcus aureus. I. Purification and characterization of one neutral and one alkaline protease.

Authors:  S Arvidson; T Holme; B Lindholm
Journal:  Biochim Biophys Acta       Date:  1973-03-15

7.  Description of staphylococcus serine protease (ssp) operon in Staphylococcus aureus and nonpolar inactivation of sspA-encoded serine protease.

Authors:  K Rice; R Peralta; D Bast; J de Azavedo; M J McGavin
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

8.  The function of propeptide domains of cysteine proteinases.

Authors:  B Wiederanders
Journal:  Adv Exp Med Biol       Date:  2000       Impact factor: 2.622

9.  Coexpression of proteins in bacteria using T7-based expression plasmids: expression of heteromeric cell-cycle and transcriptional regulatory complexes.

Authors:  K Johnston; A Clements; R N Venkataramani; R C Trievel; R Marmorstein
Journal:  Protein Expr Purif       Date:  2000-12       Impact factor: 1.650

10.  A novel class of cysteine protease inhibitors: solution structure of staphostatin A from Staphylococcus aureus.

Authors:  Grzegorz Dubin; Marcin Krajewski; Grzegorz Popowicz; Justyna Stec-Niemczyk; Matthias Bochtler; Jan Potempa; Adam Dubin; Tad A Holak
Journal:  Biochemistry       Date:  2003-11-25       Impact factor: 3.162

View more
  5 in total

1.  Staphopains modulate Staphylococcus aureus biofilm integrity.

Authors:  Joe M Mootz; Cheryl L Malone; Lindsey N Shaw; Alexander R Horswill
Journal:  Infect Immun       Date:  2013-06-24       Impact factor: 3.441

Review 2.  Prokaryote-derived protein inhibitors of peptidases: A sketchy occurrence and mostly unknown function.

Authors:  Tomasz Kantyka; Neil D Rawlings; Jan Potempa
Journal:  Biochimie       Date:  2010-06-14       Impact factor: 4.079

Review 3.  A novel endogenous inhibitor of the secreted streptococcal NAD-glycohydrolase.

Authors:  Michael A Meehl; Jerome S Pinkner; Patricia J Anderson; Scott J Hultgren; Michael G Caparon
Journal:  PLoS Pathog       Date:  2005-12-02       Impact factor: 6.823

4.  Eukaryotic translation initiation factor 5A and its posttranslational modifications play an important role in proliferation and potentially in differentiation of the human enteric protozoan parasite Entamoeba histolytica.

Authors:  Ghulam Jeelani; Tomoyoshi Nozaki
Journal:  PLoS Pathog       Date:  2021-02-16       Impact factor: 6.823

Review 5.  Regulation of bacterial protease activity.

Authors:  Benedykt Władyka; Katarzyna Pustelny
Journal:  Cell Mol Biol Lett       Date:  2008-04-10       Impact factor: 5.787

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.